Coloplast A/S (FRA:CBHD)

Market Cap	14.56B -39.6%
Revenue (ttm)	3.73B +1.6%
Net Income	534.11M -18.3%
EPS	2.37 -18.4%
Shares Out	n/a
PE Ratio	27.25
Forward PE	18.72
Dividend	3.08 (4.75%)
Ex-Dividend Date	Dec 5, 2025

Volume	2
Average Volume	437
Open	64.26
Previous Close	64.80
Day's Range	64.26 - 65.08
52-Week Range	64.00 - 108.15
Beta	n/a
RSI	37.64
Earnings Date	Feb 6, 2026

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories ...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1954
• Employees: 16,983
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CBHD

Financial Performance

In fiscal year 2025, Coloplast's revenue was 27.87 billion, an increase of 3.12% compared to the previous year's 27.03 billion. Earnings were 3.64 billion, a decrease of -28.03%.

Financial numbers in DKK